Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
2,115 people get COV articles and Market Currents by email alert.
Get email alerts on COV »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Thu, 7:00AM)
-
Business Wire (Mon, 8:00AM)
-
-
Business Wire (May 13, 2013)
-
Business Wire (May 13, 2013)
-
Covidien Aiming For Mallinckrodt Spin-OutEP Vantage • Wed, May 8 -
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 3, 2013)
-
-
At These Levels, Covidien Has Room To RunStephen Barnes • Tue, Apr 30 -
-
Business Wire (Apr 26, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
Covidien Aiming For Mallinckrodt Spin-OutEP Vantage • Wed, May 8
-
At These Levels, Covidien Has Room To RunStephen Barnes • Tue, Apr 30
-
-
-
-
Covidien - A Leading Growth Story At A Reasonable PriceStephen Simpson • Thu, Jul 26, 2012
-
Covidien: Earnings PreviewZacks Investment Research • Mon, Jul 23, 2012 -
-
-
Covidien Plays To Its Strengths And Still Looks UndervaluedStephen Simpson • Fri, Jan 27, 2012
-
Why Covidien Will Surge 50% As Hospira StrugglesTakeover Analyst • Fri, Jan 20, 2012 -
The Search For Rising Dividends: Covidien PLCK202 • Tue, Jan 10, 2012 -
Covidien: Earnings PreviewZacks Investment Research • Mon, Nov 14, 2011
-
Covidien: Defensive Stock Pick With Strong Technical SupportBret Jensen • Sun, Oct 16, 2011 -
Covidien Gets FDA NodZacks Investment Research • Fri, Mar 11, 2011
-
-
Covidien Backs FDA Safety WarningZacks Investment Research • Tue, Sep 14, 2010
-
-
-
-
-
-
-
-
-
CareFusion On The Right PathStephen Simpson • Wed, Apr 3
-
-
-
-
-
-
-
-
-
-
3 Stocks With Recent Intensive Insider SellingMarkus Aarnio • Sun, Feb 24 -
-
Covidien's CEO Discusses F4Q 2012 Results - Earnings Call TranscriptFri, Nov 9, 2012
-
Covidien Management Discusses Q3 2012 Results - Earnings Call TranscriptThu, Jul 26, 2012
-
Covidien's CEO Discusses Q2 2012 Results - Earnings Call TranscriptFri, Apr 27, 2012
-
Covidien plc's CEO Discusses Q1 2012 Results - Earnings Call TranscriptThu, Jan 26, 2012 • 1 Comment
-
Covidien plc - Shareholder/Analyst CallThu, Dec 15, 2011
-
Covidien plc - Analyst/Investor DayThu, Sep 8, 2011
-
Covidien plc's CEO Discusses Q2 2011 Results - Earnings Call TranscriptThu, Apr 21, 2011
-
Covidien CEO Discusses Q1 2011 Results - Earnings Call TranscriptTue, Feb 1, 2011
-
Covidien CEO Discusses F4Q10 Results - Earnings Call TranscriptTue, Nov 9, 2010
-
Covidien Ltd. F3Q10 (Qtr End 6/30/10 Earnings Call TranscriptThu, Jul 29, 2010
-
Covidien Ltd. F2Q10 (Qtr End 03/26/10) Earnings Call TranscriptWed, Apr 21, 2010
-
Business Wire (Thu, 7:00AM)
-
Business Wire (Mon, 8:00AM)
-
at CNBC.com (Fri, 6:02PM)
-
Business Wire (May 13, 2013)
-
Business Wire (May 13, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 3, 2013)
-
at MarketWatch.com (Apr 26, 2013)
-
Business Wire (Apr 26, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 15, 2013)
-
Business Wire (Apr 11, 2013)
-
Business Wire (Mar 29, 2013)
-
Business Wire (Mar 25, 2013)
-
Business Wire (Mar 21, 2013)
-
Business Wire (Mar 20, 2013)
COV vs. ETF Alternatives
Company Description
We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presence in non-U.S. markets. Our mission is to create and... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 11, 12:37 PM Covidien (COV +1.1%) says it's entered into an agreement with VIDA Diagnostics to distribute it's Apollo pulmonary imaging software services. The agreement enables COV to offer a combination of technologies from VIDA and Covidien's i-Logic lung navigation system, which provides physicians with enhanced detail for the minimally invasive diagnosis and treatment planning of a variety of lung diseases. Comment! [Healthcare, Global & FX, On the Move]
- Monday, August 27, 2012, 12:03 PM Zalicus (ZLCS +11.1%) takes off after announcing the FDA has approved the sale of 32mg tablets for Covidien's (COV +0.6%) Exalgo pain-relief drug. The sale of 8, 12, and 16mg tablets was approved in 2010. Zalicus receives royalties on Exalgo sakes. (PR) 2 Comments [Healthcare, On the Move]
- Monday, July 30, 2012, 11:14 AM Covidien (COV +1.2%) continues the rise it began on Tuesday last week ahead of its FQ3 EPS beat on Thursday and hits a new 52-week high of $56.21. SA author Stephen Simpson calls Covidien "a leading growth story at a reasonable price." The company today said it has received 510(K) clearance for its Nellcor Bedside SpO2 Patient Monitoring System. 1 Comment [Healthcare, On the Move]
- Thursday, July 26, 2012, 2:00 PM Covidien (COV +4.4%) is trading higher today after beating FQ3 bottom-line estimates by a penny. Sales gained 2.8% to $3.01B, which was in line with consensus, but net earnings fell by 15% Y/Y as the maker of operating-room gear and other medical products deals with challenging conditions in Europe. 1 Comment [Global & FX, Earnings, On the Move, Healthcare]
- Thursday, January 19, 2012, 3:49 PM Covidien (COV +3.8%) expands a recall of sensors used to monitor patients under anesthesia because of a modification that could result in inaccurate data, following a separate voluntary recall announced earlier this week. A J.P. Morgan analyst says COV's core medical devices business looks healthy despite broader challenges facing the industry. Comment! [Healthcare, On the Move]
-
Thursday, December 15, 2011, 9:05 AM
Premarket gainers: SONO +27%. NVLS +23%. CEDC +17%. AMR +11%. RAD +5%. ACHC +6%. MTL +5%. ING +5%. GMCR +4%. DB +4%. FDX +4%. WLT +4%. ANR +5%. COV +4%. PBR +4%. NVS +3%. STD +3%. MS +3%. BCS +3%. CLWR +3%. RDN +3%. ARIA +3%. ARMH +3%. C +3%.
Losers: AIS -22%. DECK -7%. DMND -7%. Comment! [On the Move] - Thursday, December 1, 2011, 1:55 PM Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the company's SpiderFX, an embolic protection device for the treatment of severely calcified arterial lesions in the lower extremities. Comment! [Healthcare, On the Move]
- Tuesday, November 15, 2011, 1:37 PM Covidien (COV +2.4%) gains after its FQ4 EPS easily beat estimates. Earnings rose 1.8% Y/Y, fueled by growth in its medical-devices business and an extra week of sales that boosted revenue by 7% - 8% during the period. The company also boosts FY12 sales guidance to an increase of around 3% - 5% due to positive FX rates. Comment! [Healthcare, On the Move]
- Monday, August 1, 2011, 3:09 PM On any other day this stock would be trading higher, but not today. Covidien (COV -2.2%) trades lower with the rest of the weak healthcare sector despite announcing its morphine sulfate solution Mallinckrodt - a hospice-related pain drug - has just been approved by the FDA. Comment! [Healthcare, On the Move]
- Tuesday, July 26, 2011, 10:15 AM More on Covidien (COV +4.3%): FQ3 earnings jumped 47% as acquisitions and new products from its medical devices unit continue to drive sales growth and offset anemic performance from its pharmaceuticals group. Comment! [Healthcare, On the Move]
-
Tuesday, July 26, 2011, 9:00 AM
Premarket gainers: SONE +29%. APP +23%. RSH +19%. GRA +9%. SVU +8%. BRCM +9%. CIGX +8%. WFT +8%. BIDU +6%. CMI +6%. COV +5%. RENN +4%. YOKU +3%. GSK +3%.
Losers: LII -11%. VDSI -9%. EK -9%. STM -9%. NFLX -8%. FNDT -7%. WAT -7%. AKS -6%. QGEN -3%. NVDA -3%. MMM -3%. 1 Comment [On the Move]
-
- View all 0 replies
-
- View all 0 replies
-
neobliviscar
Anyone else looking at bottom ticking the bleeders $COV and $BLL ? Where would you get in? - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
$LSE $ABM and $BBD are tomorrow's best yielding ex-dividend stocks - http://stks.co/dOtj - 12 shares with 3.09% average yield $COV - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
$NGG $SNY and $CS are the best yielding stocks with buy or better rating from Europe + http://stks.co/eJcR + I like $NVO $BUD and $COV - View all 0 replies
-
- View all 4 replies
-
-
Dr. Kris: Bob: I'm dubbing you the official SA music director. Each stock should have its own theme song.
-
Dividend Sheet
$HLF $SNY and $COV are the best yielding stocks from the top 20 buy rated healthcare stocks + http://stks.co/cHAs + I also like $NVO $COO - View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 4 replies
-
-
Dr. Kris: Bob: I'm dubbing you the official SA music director. Each stock should have its own theme song.
-
- View all 3 replies
-
FortSumter: Sorry, my background was more large scale products for hospital and home health care.
-
-
- View all 8 replies
-
-
Jeremy Johnson: STJ is not expensive, but it is getting close to fair value. Fair value stocks are still good to own... fair equity return is 8% a year.